Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAIREITO study: Saireito after catheter ablation for atrial fibrillation
jRCTs051200037Completed
- Sponsor
- Operation Cost Grant
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of saireito in Atrial fibrillation (AFib) (2 arms), sponsored by Operation Cost Grant. Primary endpoint: Early recurrence of atrial arrhythmia within 90 days after catheter ablation. Started Aug 2020; status: completed.
02
Drugs
saireito
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCTs051200037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200037.